The expression of miR-145 is upregulated in gastric cancer, which inhibits the expression of catenin (cadherin-associated protein), delta 1 (CTNND1), and N-cadherin while promoting the translocation of CTNND1 and E-cadherin from the cytoplasm to the cell membrane. This evidence concerns the gene CTNND1 and gastric cancer.